
Coherus Oncology Raises $50.1M in Stock Offering to Fund Oncology Pipeline
Coherus Oncology raised $50.1M through stock offering to fund commercial launch of LOQTORZI and advance its oncology pipeline development.
CHRSclinical developmentpublic offering